Dkk3 inhibits the aggressiveness and mitigates chemoresistance through low lipid droplet formation in gastric cancer: A biomarker and gene therapy target
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114200 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Ren-Xiang Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center of Translational Medicine and Cancer Center, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001 China; Department of …. Hauptthemen laut MEDLINE: Stomach Neoplasms, Lipid Droplets, Adaptor Proteins, Signal Transducing, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Distinguished Professor of Liaoning Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Dkk3 is discovered through comparative studies of immortalized cells and their parental counterparts and might inhibit the aggressive phenotypes in malignant cells, demonstrating its tumor-suppressor activity. Here, we explored the clinicopathological significance of Dkk3 expression, the association between Dkk3 expression and immune microenvironment, and Dkk3-related signal pathways in gastric cancer (GC), and discovered the effects of Dkk3 on aggressiveness, chemoresistance and lipid droplet formation with molecular mechanisms investigated. Our data showed that plasma level of Dkk3 was low in GC and Dkk3 expression was negatively correlated with younger age, tumor size, depth of invasion, lymph node metastasis, clinicopathological stage and histological classification of GC. Additionally our study shows DKK3 have a potential impact on GC immunity by regulating immune cell infiltration. Overexpression of wild-type and no-signal peptide Dkk3 inhibited cell proliferation, promoted apoptotic and pyroptotic cell death, and suppressed invasion, migration and epithelial-mesenchymal transition in GC cells. Furthermore, Dkk3 expression promoted chemosensitivity by weakening lipid droplet formation in GC cells. The Dkk3-related pathways included ECM (extracellular matrix)-receptor interactions, ECM constituents and organization, WP miRNA targets in ECM membrane receptors, focal adhesion, cAMP, calcium and integrin signaling pathways, basement membranes, spliceosome activity, mitochondrial oxidative phosphorylation, and ubiquitin-like protein binding. These results indicate that Dkk3 expression may serve as a valuable indicator to evaluate the pathological behaviors and immunotherapy of GC. Additionally, Dkk3 could potentially inhibit the aggressiveness regardless of signal peptide, and alleviate chemoresistance by low lipid droplet formation, making it become a valuable molecular target for gene therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Translational Medicine and Cancer Center, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001 China; Department of Oncology, The Affiliated Hospital of Chengde Medical University, Cheng…
- Department of Gastric Surgery, Liaoning Cancer Hospital, Shenyang 110042 China.
- Center of Translational Medicine and Cancer Center, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001 China.
- Department of Environmental Health, University of Fukui School of Medical Sciences, Fukui 910-1193 Japan.
- Center of Translational Medicine and Cancer Center, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001 China. Electronic address: zheng_huachuan@hotmail.com.
Förderung
- Distinguished Professor of Liaoning Province
- National Natural Science Foundation of China
Zitieren
APA
Liu, R. X., Zheng, G. L., Li, N., Cui, Z. G., & Zheng, H. C. (2025). Dkk3 inhibits the aggressiveness and mitigates chemoresistance through low lipid droplet formation in gastric cancer: A biomarker and gene therapy target. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114200
Vancouver
Liu RX, Zheng GL, Li N, Cui ZG, Zheng HC. Dkk3 inhibits the aggressiveness and mitigates chemoresistance through low lipid droplet formation in gastric cancer: A biomarker and gene therapy target. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114200
BibTeX
@article{Liu2025,
author = {Liu, Ren-Xiang and Zheng, Guo-Liang and Li, Ning and Cui, Zheng-Guo and Zheng, Hua-Chuan},
title = {Dkk3 inhibits the aggressiveness and mitigates chemoresistance through low lipid droplet formation in gastric cancer: A biomarker and gene therapy target},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114200}
}
EUVIMED